SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.
TLDR
In this paper, the expression and localization of host mRNAs during SARS-CoV-2 infection were examined using single-molecule RNA visualization, and it was shown that the biogenesis of type I and type III IFN genes is inhibited at multiple steps during infection.Abstract:
The transcriptional induction of interferon (IFN) genes is a key feature of the mammalian antiviral response that limits viral replication and dissemination. A hallmark of severe COVID-19 disease caused by SARS-CoV-2 is the low presence of IFN proteins in patient serum despite elevated levels of IFN-encoding mRNAs, indicative of post-transcriptional inhibition of IFN protein production. Here, we performed single-molecule RNA visualization to examine the expression and localization of host mRNAs during SARS-CoV-2 infection. Our data show that the biogenesis of type I and type III IFN mRNAs is inhibited at multiple steps during SARS-CoV-2 infection. First, translocation of the interferon regulatory factor 3 (IRF3) transcription factor to the nucleus is limited in response to SARS-CoV-2, indicating that SARS-CoV-2 inhibits RLR-MAVS signaling and thus weakens transcriptional induction of IFN genes. Second, we observed that IFN mRNAs primarily localize to the site of transcription in most SARS-CoV-2 infected cells, suggesting that SARS-CoV-2 either inhibits the release of IFN mRNAs from their sites of transcription and/or triggers decay of IFN mRNAs in the nucleus upon exiting the site of transcription. Lastly, nuclear-cytoplasmic transport of IFN mRNAs is inhibited during SARS-CoV-2 infection, which we propose is a consequence of widespread degradation of host cytoplasmic basal mRNAs in the early stages of SARS-CoV-2 replication by the SARS-CoV-2 Nsp1 protein, as wells as the host antiviral endoribonuclease, RNase L. Importantly, IFN mRNAs can escape SARS-CoV-2-mediated degradation if they reach the cytoplasm, making rescue of mRNA export a viable means for promoting the immune response to SARS-CoV-2.read more
Citations
More filters
Journal ArticleDOI
Innate immunity: the first line of defense against SARS-CoV-2
TL;DR: Kanneganti et al. as discussed by the authors reviewed the key role played by innate immunity in the control and immunopathology of COVID-19 and discussed innate immune processes involved in SARS-CoV-2 recognition and the resultant inflammation.
Journal ArticleDOI
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.
Mona Khan,Seung-Jun Yoo,Marnick Clijsters,Wout Backaert,Arno Vanstapel,Kato Speleman,Charlotte Lietaer,Sumin Choi,Tyler Hether,Lukas Marcelis,Andrew Nam,Liuliu Pan,Jason Reeves,Pauline Van Bulck,Hai Zhou,Marc Bourgeois,Yves Debaveye,Paul De Munter,Jan Gunst,Mark Jorissen,Katrien Lagrou,Natalie Lorent,Arne Neyrinck,Marijke Peetermans,Dietmar Rudolf Thal,Christophe Vandenbriele,Joost Wauters,Peter Mombaerts,Laura Van Gerven +28 more
TL;DR: It is postulate that transient insufficient support from sustentacular cells triggers transient olfactory dysfunction in COVID-19, and SARS-CoV-2 does not appear to be a neurotropic virus.
Journal ArticleDOI
ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection
TL;DR: In this paper , the authors found that IFN induced Z-DNA-binding protein 1 (ZBP1)-mediated inflammatory cell death, PANoptosis, in human and murine macrophages and in the lungs of mice infected with β-coronaviruses, including SARS-CoV-2 and mouse hepatitis virus (MHV).
Journal ArticleDOI
Type I Interferons in COVID-19 Pathogenesis.
TL;DR: In this article, the authors summarize the virus-mediated evasion of the type I interferon (IFN) responses and the viral functions involved, the genetic basis of IFN production in SARS-CoV-2 infection and the progress of clinical trials designed to utilize type I IFN as a potential therapeutic tool.
Journal ArticleDOI
Phase separation by the SARS-CoV-2 nucleocapsid protein: Consensus and open questions
Sean M. Cascarina,Eric D. Ross +1 more
TL;DR: In this article , the authors discuss emerging observations of phase separation by the SARS-CoV-2 nucleocapsid (N) protein and the possible in vivo functions that have been proposed for N-protein phase separation, including viral replication, viral genomic RNA packaging, and modulation of host-cell response to infection.
References
More filters
Journal ArticleDOI
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Daniel Blanco-Melo,Benjamin E. Nilsson-Payant,Wen-Chun Liu,Skyler Uhl,Daisy A. Hoagland,Rasmus Møller,Tristan X. Jordan,Kohei Oishi,Maryline Panis,David H. Sachs,Taia T. Wang,Robert E. Schwartz,Jean K. Lim,Randy A. Albrecht,Benjamin R. tenOever +14 more
TL;DR: It is proposed that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.
Journal ArticleDOI
Regulation of type I interferon responses
TL;DR: In this paper, the authors summarize the signalling and epigenetic mechanisms that regulate type I IFN-induced STAT activation and ISG transcription and translation and conclude that these regulatory mechanisms determine the biological outcomes of type I ILN responses and whether pathogens are cleared effectively or chronic infection or autoimmune disease ensues.
Journal ArticleDOI
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Jérôme Hadjadj,Nader Yatim,Laura Barnabei,Aurélien Corneau,Jeremy Boussier,Nikaïa Smith,Hélène Péré,Bruno Charbit,Vincent Bondet,Camille Chenevier-Gobeaux,Paul Breillat,Nicolas Carlier,Rémy Gauzit,Caroline Morbieu,Frédéric Pène,Nathalie Marin,Nicolas Roche,Tali Anne Szwebel,Sarah H. Merkling,Jean-Marc Treluyer,David Veyer,Luc Mouthon,Catherine Blanc,Pierre-Louis Tharaux,Flore Rozenberg,Alain Fischer,Alain Fischer,Alain Fischer,Darragh Duffy,Frédéric Rieux-Laucat,Solen Kernéis,Solen Kernéis,Benjamin Terrier +32 more
TL;DR: The results of this trio of studies suggest that the location, timing, and duration of IFN exposure are critical parameters underlying the success or failure of therapeutics for viral respiratory infections.
Journal ArticleDOI
A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
Aaron J. Wilk,Arjun Rustagi,Nancy Q. Zhao,Jonasel Roque,Giovanny J Martínez-Colón,Julia L. McKechnie,Geoffrey T. Ivison,Thanmayi Ranganath,Rosemary Vergara,Taylor Mi Hollis,Laura J. Simpson,Philip M. Grant,Aruna Subramanian,Albert J. Rogers,Catherine A. Blish +14 more
TL;DR: Single-cell transcriptomic analysis identifies changes in peripheral immune cells in seven hospitalized patients with COVID-19, including HLA class II downregulation, a heterogeneous interferon-stimulated gene signature and low pro-inflammatory cytokine gene expression in monocytes and lymphocytes.
Journal ArticleDOI
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
Zhuo Zhou,Zhuo Zhou,Lili Ren,Li Zhang,Jiaxin Zhong,Jiaxin Zhong,Yan Xiao,Jia Zhilong,Li Guo,Jing Yang,Jing Yang,Chun Wang,Chun Wang,Shuai Jiang,Donghong Yang,Guoliang Zhang,Hongru Li,Fuhui Chen,Yu Xu,Mingwei Chen,Zhancheng Gao,Jian Yang,Jie Dong,Bo Liu,Xiannian Zhang,Weidong Wang,Kunlun He,Qi Jin,Mingkun Li,Mingkun Li,Mingkun Li,Jianwei Wang +31 more
TL;DR: The expression of proinflammatory genes, especially chemokines, was markedly elevated in COVID-19 cases compared to community-acquired pneumonia patients and healthy controls, suggesting that SARS-CoV-2 infection causes hypercytokinemia.
Related Papers (5)
SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.
Yize Li,David M. Renner,Courtney E. Comar,Jillian N. Whelan,Hanako M. Reyes,Fabian L. Cardenas-Diaz,Rachel Truitt,Li Hui Tan,Beihua Dong,Konstantinos-Dionysios Alysandratos,Jessie Huang,James N. Palmer,Nithin D. Adappa,Michael A. Kohanski,Darrell N. Kotton,Robert H. Silverman,Wenli Yang,Edward E. Morrisey,Noam A. Cohen,Noam A. Cohen,Noam A. Cohen,Susan R. Weiss +21 more